What is the address of Midiclinic?

The registered office of Midiclinic is located at Kaudenaardestraat 122, 1700 Dilbeek.

Is Midiclinic still active?

Yes. According to the CBE (15 November 2026) Midiclinic is active, legal situation “Normale toestand”, started on 12 August 2011.

Is Midiclinic registered on Peppol?

Yes, Midiclinic is registered on the Peppol network with ID 0208:0838529465.

What is the enterprise number of Midiclinic?

The enterprise number of Midiclinic is BE0838529465.

When was Midiclinic founded?

Midiclinic was founded on 12 August 2011.

Who are the directors of Midiclinic?

According to the 2025 annual accounts, the directors of Midiclinic are: Abdsamad Ahkim.

Is Midiclinic a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 12 August 2011; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Midiclinic make in 2025?

Midiclinic recorded a loss after taxes of € 12,795 in financial year 2025.

What is the revenue of Midiclinic?

As a small company, Midiclinic is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 112,001.

Midiclinic (Private Limited) - Dilbeek - BE0838529465

Q: What does Midiclinic do?

Midiclinic is registered with the CBE as active in: Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies. Private Limited, started on 12 August 2011, 1 establishment.

Dossier Midiclinic, printed on 15 November 2026 from databakkes.be/en/0838529465/midiclinic. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Negative equity NBB

More debt than assets in 3 of the last 4 fiscal years.
Two loss years in a row NBB

Negative result in 2024 and 2025.
Tight liquidity NBB

Cash and receivables cover 42 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

Midiclinic from Dilbeek, company number BE0838529465, closed financial year 2025 with a result of € -12,795 after tax. For that financial year Midiclinic recorded a gross margin of € 112,001 and equity of € -62,125. Compared with financial year 2024, the result moved from € -52,670 to € -12,795. The company made a loss. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on July 31, 2026.

What it is worth Caution

€ -62,125

▼ € 12,795 vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -12,795

▲ 76 % less loss than in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 29,673

▲ € 23,881 vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € -80,725.

People and assets in 2025

Full-time equivalents estimate

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Wage cost

€ 90,968

▲ 135% vs 2024

Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 3,748

▲ 26% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 70,790

▲ € 57,690 vs 2024

Supplier invoices still open on the last day of the fiscal year.

Wages and social charges

€ 21,385

▲ 10% vs 2024

Wages, holiday pay and social contributions still to pay. No outstanding taxes.

Key figures per fiscal year
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 30,141 Gross margin 2022: € 30,141 First fiscal year in the series	€ 1,628 Gross margin 2023: € 1,628 ▼ 95% vs 2022 (€ 30,141) Unfavourable step	€ -8,758 Gross margin 2024: € -8,758 ▼ € 10,386 vs 2023 (€ 1,628) Unfavourable step	€ 112,001 Gross margin 2025: € 112,001 ▲ € 120,759 vs 2024 (€ -8,758) Favourable step	▲ € 120,759
Profit after taxes	€ 4,894 Profit after taxes 2022: € 4,894 First fiscal year in the series	€ -39,620 Profit after taxes 2023: € -39,620 ▼ € 44,514 vs 2022 (€ 4,894) Unfavourable step	€ -52,670 Profit after taxes 2024: € -52,670 ▼ € 13,050 vs 2023 (€ -39,620) Unfavourable step	€ -12,795 Profit after taxes 2025: € -12,795 ▲ € 39,875 vs 2024 (€ -52,670) Favourable step	▲ € 39,875
Equity	€ 30,560 Equity 2022: € 30,560 First fiscal year in the series	€ -9,061 Equity 2023: € -9,061 ▼ € 39,620 vs 2022 (€ 30,560) Unfavourable step	€ -49,331 Equity 2024: € -49,331 ▼ € 40,270 vs 2023 (€ -9,061) Unfavourable step	€ -62,125 Equity 2025: € -62,125 ▼ € 12,795 vs 2024 (€ -49,331) Unfavourable step	▼ € 12,795
Total debts	€ 19,535 Total debts 2022: € 19,535 First fiscal year in the series	€ 31,474 Total debts 2023: € 31,474 ▲ 61% vs 2022 (€ 19,535) Unfavourable step	€ 198,988 Total debts 2024: € 198,988 ▲ € 167,514 vs 2023 (€ 31,474) Unfavourable step	€ 349,831 Total debts 2025: € 349,831 ▲ 76% vs 2024 (€ 198,988) Unfavourable step	▲ 76%
Cash	€ 22,394 Cash 2022: € 22,394 First fiscal year in the series	€ 1,272 Cash 2023: € 1,272 ▼ 94% vs 2022 (€ 22,394) Unfavourable step	€ 5,793 Cash 2024: € 5,793 ▲ € 4,521 vs 2023 (€ 1,272) Favourable step	€ 29,673 Cash 2025: € 29,673 ▲ € 23,881 vs 2024 (€ 5,793) Favourable step	▲ € 23,881
Retained profit	€ 24,360 Retained profit 2022: € 24,360 First fiscal year in the series	€ -15,261 Retained profit 2023: € -15,261 ▼ € 39,620 vs 2022 (€ 24,360) Unfavourable step	€ -67,931 Retained profit 2024: € -67,931 ▼ € 52,670 vs 2023 (€ -15,261) Unfavourable step	€ -80,725 Retained profit 2025: € -80,725 ▼ € 12,795 vs 2024 (€ -67,931) Unfavourable step	▼ € 12,795
Balance sheet total	€ 50,094 Balance sheet total 2022: € 50,094 First fiscal year in the series	€ 22,413 Balance sheet total 2023: € 22,413 ▼ 55% vs 2022 (€ 50,094) Unchanged	€ 149,657 Balance sheet total 2024: € 149,657 ▲ € 127,244 vs 2023 (€ 22,413) Unchanged	€ 287,706 Balance sheet total 2025: € 287,706 ▲ 92% vs 2024 (€ 149,657) Unchanged	▲ 92%

By gross margin, Midiclinic ranks 40th of 145 companies with main activity “Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies” in Dilbeek that publish figures (fiscal year 2025).

Key figures of Midiclinic, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

Ask about Midiclinic the way you would ask their accountant.

Answers from the filed annual accounts, the Belgian Official Gazette and the CBE register.

Connect ChatGPT or Claude for free

ChatGPT
Claude

Free account, no payment card. Key figures unlimited, the annual accounts and deeds of 10 companies a month. Need more? Get in touch, we are looking for our first pilot users.

What happened to Midiclinic?

What happened at Midiclinic in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 31, 2026 New annual accounts for financial year 2025: loss of € 12,795. Source: NBB ↗
Sep 1, 2011 New establishment in Brussel. KBO
Aug 12, 2011 Start of the company according to the CBE. KBO

In short

From € 4,894 profit in 2022 to € 12,795 loss in 2025.

Best year ever: 2022, with € 4,894 profit.

Original PDFs at the National Bank ↗

Management

Abdsamad Ahkim

Midiclinic

Behind Midiclinic is Abdsamad Ahkim.

Directors

According to the 2025 annual accounts

Abdsamad Ahkim

Directeur

Establishments

Establishment units

Physical locations of this company

Registered office

Kaudenaardestraat 122

1700 Dilbeek

2.201.524.074

Maurice Lemonnierlaan 94

1000 Brussel

Active since 1 September 2011

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Similar companies in Dilbeek

Same main activity (Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies), 200 active companies in Dilbeek, largest first.

POSITRON

€ 721,714 gross margin · 2025

PEETERS CONSULTING

€ 669,136 gross margin · 2025

Kurt Ceuppens

€ 625,173 gross margin · 2025

DD MANAGEMENT & CONSULTING

€ 374,038 gross margin · 2025

eFLUX

€ 353,383 gross margin · 2025

VAN LONDERSELE

€ 337,848 gross margin · 2025

All companies with this activity → Largest companies in Dilbeek →

Details

Company number

0838.529.465

VAT number

BE 0838.529.465

Registered office

Kaudenaardestraat 122, 1700 Dilbeek

Names & denominations

Midiclinic

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

12 August 2011

Peppol

Active · Active since 10 Jun 2026

Activities · NACE

Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies

Schoonheidsverzorging en andere schoonheidsbehandelingen

Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering

View on CBE Public ↗ Annual accounts (NBB) ↗

Midiclinic

Warning lights

Financials

Ask about Midiclinic the way you would ask their accountant.

What happened to Midiclinic?

Management

Directors

Establishments

Establishment units

Similar companies in Dilbeek

Details

Frequently asked questions